343 related articles for article (PubMed ID: 35341404)
1. Canine and murine models of osteosarcoma.
Beck J; Ren L; Huang S; Berger E; Bardales K; Mannheimer J; Mazcko C; LeBlanc A
Vet Pathol; 2022 May; 59(3):399-414. PubMed ID: 35341404
[TBL] [Abstract][Full Text] [Related]
2. Canine osteosarcoma: a naturally occurring disease to inform pediatric oncology.
Fenger JM; London CA; Kisseberth WC
ILAR J; 2014; 55(1):69-85. PubMed ID: 24936031
[TBL] [Abstract][Full Text] [Related]
3. Comparative biology of human and canine osteosarcoma.
Mueller F; Fuchs B; Kaser-Hotz B
Anticancer Res; 2007; 27(1A):155-64. PubMed ID: 17352227
[TBL] [Abstract][Full Text] [Related]
4. Characterization of canine osteosarcoma by array comparative genomic hybridization and RT-qPCR: signatures of genomic imbalance in canine osteosarcoma parallel the human counterpart.
Angstadt AY; Motsinger-Reif A; Thomas R; Kisseberth WC; Guillermo Couto C; Duval DL; Nielsen DM; Modiano JF; Breen M
Genes Chromosomes Cancer; 2011 Nov; 50(11):859-74. PubMed ID: 21837709
[TBL] [Abstract][Full Text] [Related]
5. A review of the association between osteosarcoma metastasis and protein translation.
Osborne TS; Khanna C
J Comp Pathol; 2012; 146(2-3):132-42. PubMed ID: 22297074
[TBL] [Abstract][Full Text] [Related]
6. Detection and targeting insulin growth factor receptor type 2 (IGF2R) in osteosarcoma PDX in mouse models and in canine osteosarcoma tumors.
Karkare S; Allen KJH; Jiao R; Malo ME; Dawicki W; Helal M; Godson DL; Dickinson R; MacDonald-Dickinson V; Yang R; Hoang B; Gorlick R; Geller DS; Dadachova E
Sci Rep; 2019 Aug; 9(1):11476. PubMed ID: 31391495
[TBL] [Abstract][Full Text] [Related]
7. An in vivo/in vitro experimental model system for the study of human osteosarcoma: canine osteosarcoma cells (COS31) which retain osteoblastic and metastatic properties in nude mice.
Shoieb AM; Hahn KA; Barnhill MA
In Vivo; 1998; 12(5):463-72. PubMed ID: 9827352
[TBL] [Abstract][Full Text] [Related]
8. Development of an intramuscular xenograft model of canine osteosarcoma in mice for evaluation of the effects of radiation therapy.
Coomer AR; Farese JP; Milner R; Taylor D; Salute ME; Rajon DA; Bova FJ; Siemann DW
Am J Vet Res; 2009 Jan; 70(1):127-33. PubMed ID: 19119958
[TBL] [Abstract][Full Text] [Related]
9. The use of naturally occurring cancer in domestic animals for research into human cancer: general considerations and a review of canine skeletal osteosarcoma.
Brodey RS
Yale J Biol Med; 1979; 52(4):345-61. PubMed ID: 115162
[TBL] [Abstract][Full Text] [Related]
10. Using canine osteosarcoma as a model to assess efficacy of novel therapies: can old dogs teach us new tricks?
Rodriguez CO
Adv Exp Med Biol; 2014; 804():237-56. PubMed ID: 24924178
[TBL] [Abstract][Full Text] [Related]
11. Comparative Immunology and Immunotherapy of Canine Osteosarcoma.
Mason NJ
Adv Exp Med Biol; 2020; 1258():199-221. PubMed ID: 32767244
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling of canine osteosarcoma reveals genes associated with short and long survival times.
Selvarajah GT; Kirpensteijn J; van Wolferen ME; Rao NA; Fieten H; Mol JA
Mol Cancer; 2009 Sep; 8():72. PubMed ID: 19735553
[TBL] [Abstract][Full Text] [Related]
13. Prognostic and predictive biomarkers of canine osteosarcoma.
Selvarajah GT; Kirpensteijn J
Vet J; 2010 Jul; 185(1):28-35. PubMed ID: 20493743
[TBL] [Abstract][Full Text] [Related]
14. Of dogs and men: comparative biology as a tool for the discovery of novel biomarkers and drug development targets in osteosarcoma.
Rankin KS; Starkey M; Lunec J; Gerrand CH; Murphy S; Biswas S
Pediatr Blood Cancer; 2012 Mar; 58(3):327-33. PubMed ID: 21990244
[TBL] [Abstract][Full Text] [Related]
15. What do we know about canine osteosarcoma treatment? Review.
Szewczyk M; Lechowski R; Zabielska K
Vet Res Commun; 2015 Mar; 39(1):61-7. PubMed ID: 25422073
[TBL] [Abstract][Full Text] [Related]
16. Losartan Blocks Osteosarcoma-Elicited Monocyte Recruitment, and Combined With the Kinase Inhibitor Toceranib, Exerts Significant Clinical Benefit in Canine Metastatic Osteosarcoma.
Regan DP; Chow L; Das S; Haines L; Palmer E; Kurihara JN; Coy JW; Mathias A; Thamm DH; Gustafson DL; Dow SW
Clin Cancer Res; 2022 Feb; 28(4):662-676. PubMed ID: 34580111
[TBL] [Abstract][Full Text] [Related]
17. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA
BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924
[TBL] [Abstract][Full Text] [Related]
18. Biology, diagnosis and treatment of canine appendicular osteosarcoma: similarities and differences with human osteosarcoma.
Morello E; Martano M; Buracco P
Vet J; 2011 Sep; 189(3):268-77. PubMed ID: 20889358
[TBL] [Abstract][Full Text] [Related]
19. Assessment of a novel nanoparticle hyperthermia therapy in a murine model of osteosarcoma.
Tuohy JL; Fogle JE; Meichner K; Borst LB; Petty CS; Griffith EH; Osborne JA; Lascelles BDX
Vet Surg; 2018 Nov; 47(8):1021-1030. PubMed ID: 30307042
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of a new histologic grading system for canine osteosarcoma.
Kirpensteijn J; Kik M; Rutteman GR; Teske E
Vet Pathol; 2002 Mar; 39(2):240-6. PubMed ID: 12009062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
